TR200103562T2 - Amiloid proteini toplanmasını önleme ve amiloid birikintilerini görüntüleme yönteminde kullanım için rodanin türevleri - Google Patents
Amiloid proteini toplanmasını önleme ve amiloid birikintilerini görüntüleme yönteminde kullanım için rodanin türevleriInfo
- Publication number
- TR200103562T2 TR200103562T2 TR2001/03562T TR200103562T TR200103562T2 TR 200103562 T2 TR200103562 T2 TR 200103562T2 TR 2001/03562 T TR2001/03562 T TR 2001/03562T TR 200103562 T TR200103562 T TR 200103562T TR 200103562 T2 TR200103562 T2 TR 200103562T2
- Authority
- TR
- Turkey
- Prior art keywords
- protein aggregation
- amyloid
- preventing
- imaging
- rhodanine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13854499P | 1999-06-10 | 1999-06-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200103562T2 true TR200103562T2 (tr) | 2002-04-22 |
Family
ID=22482512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2001/03562T TR200103562T2 (tr) | 1999-06-10 | 2000-05-31 | Amiloid proteini toplanmasını önleme ve amiloid birikintilerini görüntüleme yönteminde kullanım için rodanin türevleri |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1192143A1 (xx) |
| JP (1) | JP2003502320A (xx) |
| AU (1) | AU5311800A (xx) |
| BR (1) | BR0011441A (xx) |
| CA (1) | CA2374616A1 (xx) |
| MX (1) | MXPA01010490A (xx) |
| TR (1) | TR200103562T2 (xx) |
| WO (1) | WO2000076987A1 (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20020394A1 (es) | 2000-08-18 | 2002-06-21 | Agouron Pharma | Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2 |
| AU2003280188A1 (en) | 2002-12-06 | 2004-06-30 | Warner-Lambert Company Llc | Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k |
| US20060106077A1 (en) * | 2003-07-18 | 2006-05-18 | Pintex Pharmaceuticals, Inc. | Pin1-Modulating compounds and methods of use thereof |
| JP2010518064A (ja) | 2007-02-12 | 2010-05-27 | メルク・シャープ・エンド・ドーム・コーポレイション | Ａｄおよび関連状態の治療のためのピペラジン誘導体 |
| US8933075B2 (en) | 2010-06-17 | 2015-01-13 | Fuzians Biomedicals, Inc. | Compounds useful as antiviral agents, compositions, and methods of use |
| CN106045986B (zh) * | 2016-05-31 | 2019-12-06 | 广东工业大学 | 一种新型吩噻嗪衍生物及其制备方法与应用 |
| CN106045987B (zh) * | 2016-06-21 | 2019-04-23 | 广东工业大学 | 一种具有多功能近红外荧光磁性纳米微粒及其制备和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5740478A (en) * | 1980-08-22 | 1982-03-06 | Ono Pharmaceut Co Ltd | Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative |
| JPH01147476A (ja) * | 1987-12-03 | 1989-06-09 | Mita Ind Co Ltd | 光導電性トナー |
| JPH01147462A (ja) * | 1987-12-03 | 1989-06-09 | Mita Ind Co Ltd | 電荷発生材料およびその製法 |
| US5143929A (en) * | 1991-05-09 | 1992-09-01 | Warner-Lambert Company | 2-substituted thiazolidinone, oxazolidinone, and imidazolidinone derivatives of fenamates as antiinflammatory agents |
| EP0915090A1 (en) * | 1992-09-10 | 1999-05-12 | Eli Lilly And Company | Compounds useful as hypoglycemic agents and for treating Alzheimer's disease |
| DE4318550A1 (de) * | 1993-06-04 | 1994-12-08 | Boehringer Mannheim Gmbh | Aryliden-4-oxo-2-thioxo-3- thiazolidincarbonsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US6251928B1 (en) * | 1994-03-16 | 2001-06-26 | Eli Lilly And Company | Treatment of alzheimer's disease employing inhibitors of cathepsin D |
| AU1529297A (en) * | 1996-01-24 | 1997-08-20 | Warner-Lambert Company | Method of imaging amyloid deposits |
| EP1128832A4 (en) * | 1998-08-21 | 2003-03-05 | Viropharma Inc | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS AND RELATED DISEASES |
| EP1117655A1 (en) * | 1998-09-30 | 2001-07-25 | Angelika Esswein | Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders |
-
2000
- 2000-05-31 TR TR2001/03562T patent/TR200103562T2/xx unknown
- 2000-05-31 CA CA002374616A patent/CA2374616A1/en not_active Abandoned
- 2000-05-31 BR BR0011441-3A patent/BR0011441A/pt not_active IP Right Cessation
- 2000-05-31 EP EP00938021A patent/EP1192143A1/en not_active Withdrawn
- 2000-05-31 AU AU53118/00A patent/AU5311800A/en not_active Abandoned
- 2000-05-31 WO PCT/US2000/015069 patent/WO2000076987A1/en not_active Application Discontinuation
- 2000-05-31 MX MXPA01010490A patent/MXPA01010490A/es unknown
- 2000-05-31 JP JP2001503845A patent/JP2003502320A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1192143A1 (en) | 2002-04-03 |
| AU5311800A (en) | 2001-01-02 |
| MXPA01010490A (es) | 2005-05-27 |
| JP2003502320A (ja) | 2003-01-21 |
| WO2000076987A1 (en) | 2000-12-21 |
| BR0011441A (pt) | 2002-07-16 |
| CA2374616A1 (en) | 2000-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200200257T2 (tr) | Amiloid protein birikimi inhibisyonu ve izoindolin türevleri kullanılarak amidoid tortularının görüntülenmesi yöntemi. | |
| ATE349446T1 (de) | Amyloid plaque aggregationshemmer und diagnostische bilderzeugungsmittel | |
| ES2188584T3 (es) | Derivados heterociclicos de amina. | |
| ATE185797T1 (de) | Stilben-derivate verwendbar als cyclooxygenase-2 hemmer | |
| EA200201247A1 (ru) | Соединения для лечения болезни альцгеймера | |
| EA200000723A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
| TNSN02008A1 (fr) | Derives d'acides isophtalique nouveaux inhibiteurs de mmp, et compositions les contenant | |
| DE60226729D1 (de) | Hydroxyalkylaminderivate als beta-secretase-inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten | |
| EA200401114A3 (ru) | Замещённые гидроксиэтиламины | |
| BR0212787A (pt) | Composto ou sal farmaceuticamente aceitável do mesmo, métodos de tratamento ou prevenção de doenças e de preparação de um composto, uso de um composto ou sal, e, composição farmacêutica | |
| BR0011728A (pt) | Método de inibir a agregação de proteìna amilóide e imagem de depósitos de amilóide | |
| BR0210392A (pt) | Composto, métodos de tratar um paciente que tenha ou de prevenir um paciente de contrair uma doença ou condição e de preparar um composto, e, uso de um composto | |
| EA200300392A1 (ru) | Производные пиперазина с мостиковой связью | |
| ATE287886T1 (de) | Verwendung von 5-thio, sulfinyl- und sulfonylpyrazolo 3,4-b) pyridinen als cyclin- abhängige kinase-hemmer | |
| DK1553985T3 (da) | Biphenyler som billeddannelsesmiddel i forbindelse med Alzheimers sygdom | |
| TR200103562T2 (tr) | Amiloid proteini toplanmasını önleme ve amiloid birikintilerini görüntüleme yönteminde kullanım için rodanin türevleri | |
| DE60211746D1 (de) | Aminosäurederivate zur behandlung der alzheimer-krankheit | |
| TR200103561T2 (tr) | Rodanin türevleri ve amiloidlerin önlenmesi ve görüntülenmesinde kullanımları | |
| ATE304522T1 (de) | Verfahren zur hemmung von amyloidprotein aggregation und zur diagnostischen nachweis von amyloidablagerung unter verwendung von aminoindanderivaten | |
| AR031126A1 (es) | Acidos amino(oxo)aceticos inhibidores de la proteina tirosina fosfatasa | |
| DE69710574D1 (de) | Diclofenac/gamma-cyclodextrin klathrat komponente | |
| NO20010624D0 (no) | N-substituerte azacykloheptanderivater, fremstilling og anvendelse derav | |
| RS50412B (sr) | Derivati tiazofurina | |
| RU94033096A (ru) | Соединение, способ лечения и фармацевтическая композиция |